Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Previously submitted to: JMIR Medical Informatics (no longer under consideration since Sep 29, 2026)

Date Submitted: Sep 28, 2026
Open Peer Review Period: Sep 29, 2026 - Sep 29, 2026
(closed for review but you can still tweet)

NOTE: This is an unreviewed Preprint

Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).

Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.

Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).

Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.

Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.

Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Acupuncture Clinical Trial Registration for Vertigo: A Multi-Registry Cross-Sectional Analysis (ClinicalTrials.gov, ChiCTR, and ITMCTR, 2007–2026)

  • Qin Zhang; 
  • Lingrong Zhang; 
  • Tong Yin; 
  • Yueping Huang; 
  • Chuyun Chen

ABSTRACT

Background:

Vertigo is among the most common clinical complaints, and acupuncture is widely investigated as a non-pharmacological treatment. The acupuncture-vertigo evidence base has not, however, been characterized at the trial registration level, and no prior multi-registry analysis for this indication has included ITMCTR.

Objective:

To conduct a cross-sectional analysis of acupuncture clinical trial registrations across ClinicalTrials.gov, ChiCTR, and ITMCTR, integrating natural language processing-based screening and classification to characterize trial characteristics, intervention profiles, and registration completeness.

Methods:

We searched ClinicalTrials.gov (API v2), ChiCTR, and ITMCTR (web interfaces) using vertigo- and acupuncture-related terms. Keyword-based classification and entity extraction identified acupuncture-vertigo studies; rule-based named entity recognition captured acupoints, methods, controls, subtypes, and outcomes. Joinpoint Poisson regression characterized temporal trends, and an eight-item rubric adapted from the WHO Trial Registration Data Set scored registration completeness.

Results:

Overall, 3,520 vertigo-related trial records were retrieved (3,448 from ClinicalTrials.gov, 51 from ChiCTR, 21 from ITMCTR), yielding 55 confirmed acupuncture-vertigo trials: 29 on ClinicalTrials.gov (0.84%), 15 on ChiCTR (29.4%), and 11 on ITMCTR (52.4%). Registration density was approximately 35-fold higher in ChiCTR and 62-fold higher in ITMCTR than in ClinicalTrials.gov. Disease spectrum differed markedly: cervical vertigo predominated on the Chinese registries (ChiCTR, 40.0%) but was absent from ClinicalTrials.gov. Blinding was not stated in 27–73% of trials across registries. Registration completeness on ClinicalTrials.gov averaged 5.93 of 8 and declined significantly over two decades (β = -0.0158/year, P < .001).

Conclusions:

Acupuncture clinical trial registration for vertigo is concentrated in Chinese registries by density, yet ClinicalTrials.gov contributes nearly all internationally accessible structured data. Registry-dependent disease spectra and persistent non-reporting of blinding status underscore the need for multi-registry surveillance and standardized, etiology-specific registration as minimum conditions for evidence synthesis. Clinical Trial: N/A. This study is a secondary cross-sectional analysis of publicly available, de-identified clinical trial registry records (ClinicalTrials.gov, ChiCTR, and ITMCTR). It did not involve human participants and therefore did not require prospective trial registration.


 Citation

Please cite as:

Zhang Q, Zhang L, Yin T, Huang Y, Chen C

Acupuncture Clinical Trial Registration for Vertigo: A Multi-Registry Cross-Sectional Analysis (ClinicalTrials.gov, ChiCTR, and ITMCTR, 2007–2026)

JMIR Preprints. 28/09/2026:112591

DOI: 10.2196/preprints.112591

URL: https://preprints.jmir.org/preprint/112591

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.